Nebulizer Market Research Report: By Product Type (Pneumatic, Ultrasonic, Mesh), Portability (Portable, Stand-Alone), Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis), End User (Hospitals and Ambulatory Surgical Centers, Emergency Centers, Clinics) - Global Industry Analysis and Growth Forecast to 2030

Market Outlook

The nebulizer market size was $765.1 million in 2019, and it is projected to reach $1,698.1 million by 2030, progressing at a CAGR of 7.4% during 2020–2030. The growth can be ascribed to the rising geriatric population, soaring consumption of cigarettes, surging cases of respiratory diseases, and growing prevalence of COVID-19.

The outbreak of COVID-19 has therefore accelerated the demand for nebulizers, as it is essentially a respiratory disease. As this disease impairs breathing, the increasing number of COVID cases has led to the rapid procurement of nebulizers, globally.

Pneumatic Nebulizers Remain in Highest Demand

The pneumatic nebulizer category of the product type segment generates the highest revenue presently, as pneumatic nebulizers are durable and offer a range of particle sizes, with no medication limitations. As a result, these variants are popular among patients, primarily the elderly.

Portable Nebulizers To Witness Faster Growth

The portable nebulizer category will register the faster growth within the portability segment in the coming years. This will be due to the burgeoning geriatric population and its mounting demand for convenient treatment. The World Population Ageing 2019 report by the United Nations (UN) estimates that the population of people aged 65 years or above will rise from 703 million in 2019 to 1.5 billion by 2050.

Nebulizer Usage Widest among Asthma Patients

The asthma category, in the application segment, held the largest share in the nebulizer market in 2019 due to the surging number of asthma cases. According to the World Health Organization (WHO), more than 339 million people are presently suffering from asthma, and it is the most-common chronic ailment among children.

Hospitals and Ambulatory Surgical Centers (ASCs) Are Largest End Users

The hospitals and ASCs category, within the end user segment, dominates the market for nebulizers, and the trend is expected to continue during 2020–2030. This can be owed to the greater footfall of patients at these healthcare units and easy accessibility of hospitals to people of all income levels.

North America Generates Highest Revenue

North America generated the highest revenue from the sale of nebulizers in 2019 due to the high prevalence of respiratory diseases, product launches, and huge healthcare expenditure in the region. For instance, Koninklijke Philips N.V. announced the launch of InnoSpire Go for the U.S. market in October 2018. It is a small, easy-to-use, and lightweight portable handled nebulizer system, which is designed to deliver the medication quickly, thereby reducing the treatment time.

Asia-Pacific (APAC) To Display Fastest Growth

The APAC region is expected to record the fastest growth in the nebulizer market till 2030 due to the mounting demand for generic nebulized drugs, soaring number of tobacco smokers, increasing healthcare spending, and rising air pollution levels. Countries such as China, Japan, and India have a large number of cigarette users, which has led to a substantial rise in the cases of respiratory diseases. Owing to these reasons, the requirement for nebulizers will accelerate in the coming years.

Collaborations among Players Trending in Market

Companies in the nebulizer industry are collaborating with each other to develop advanced products. For example, in March 2020, Ventec Life Systems Inc. and General Motors Company collaborated with a U.S.-based private-sector organization, StopTheSpread.org, to amplify the production of respiratory care products to combat the coronavirus spread.

Rising Incidence of Respiratory Diseases Is Prime Growth Driver

The WHO estimates that more than three million people die of chronic obstructive pulmonary disease (COPD) each year, thereby accounting for nearly 6% of the global deaths. The organization also mentions that 90% of the COPD deaths occur in low- and middle-income countries. Nebulizers are required to treat these patients; hence, a large number of respiratory disorder cases are driving nebulizer market, by leading to the rising procurement of such medical devices by healthcare centers and individuals.

Surging Geriatric Population Is Facilitating Market Growth

According to the World Population Ageing 2019 report, the APAC region is home to the largest number of older people in the world. In APAC, there were 395.3 million elderly people in 2019, and their number is expected to increase to 954.7 million by 2050. Aging is a common risk factor for pulmonary diseases, which require nebulization therapy.

Soaring Healthcare Spending Is Pulling Market Growth

The increasing healthcare expenditure is playing a vital role in the growth of the market for nebulizers. A 2019 report by the WHO revealed a rapid surge in the worldwide health spending, which was primarily noticeable in low- and middle-income countries, where it has been growing at a higher average rate than in high-income nations. Furthermore, the World Bank reveals that the healthcare expenditure increased from 9.04% of the world’s gross domestic product (GDP) in 2007 to 9.89% of the global GDP in 2017. The rising healthcare spending enhances the purchasing power and expenditure on healthcare of an individual, which, in turn, drives nebulizer sales.

Key Players Are Launching Products to Gain Competitive Edge in Global Market

The global nebulizer market is highly competitive in nature, with the giant players involved in launching new products, along with various public awareness programs, in order to enhance their portfolio and brand image. Additionally, smaller players are strengthening their finances and exploring new avenues to establish themselves in the market.

For instance, in June 2020, Respira Technologies Inc. launched its pharmaceutical-focused commercial development program for the RespiRx drug delivery platform. RespiRx is an ultra-portable handheld vibrating mesh nebulizer for local and systemic treatment.

Similarly, in March 2018, Convexity Scientific Inc. launched its Flyp nebulizer for patients with asthma and COPD. It includes a vibrating internal disk that produces an inhalable aerosol mist, to deliver medication deep into the patients’ lungs. As per the company, the device is powered by a rechargeable lithium-ion battery, and it can deliver 10 treatments on a single charge.

Key Players in Nebulizer Market include:

Nebulizer Market Size Breakdown by Segment

The nebulizer market report offers comprehensive market segmentation analysis along with market estimation for the period 2014–2030.

Based on Product Type

• Pneumatic
  • Breath-actuated
  • Vented
• Ultrasonic
• Mesh
  • Vibrating mesh
  • Static mesh

Based on Portability

• Portable
• Stand-Alone

Based on Application

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Cystic Fibrosis

Based on End User

• Hospitals and Ambulatory Surgical Centers (ASCs)
• Emergency Centers
• Clinics

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  •  France
  • U.K.
  • Italy
  • Spain
• Asia-Pacific (APAC)
  • China
  • India
  • Japan
  •  Australia
• Latin America (LATAM)
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia